Skip to content
Search

Latest Stories

Pharmacy First threshold increase: Community Pharmacy England urges Ministers to act

Pharmacy First threshold increase: Community Pharmacy England urges Ministers to act

Community pharmacies cannot afford to lose out on this monthly Pharmacy First payment amidst a funding crisis - Janet Morrison 

Community Pharmacy England (CPE) has voiced concerns that pharmacy owners may find it challenging to achieve the increased Pharmacy First thresholds planned for September and October.

Following initial representations by CPE, Ministers agreed to temporarily reduce the threshold to 15 for August.


However, with no further updates since, the Pharmacy First threshold is set to rise to 20 clinical pathway consultations in September.

Janet Morrison, Chief Executive of Community Pharmacy England, expressed her concerns, stating: “The ability of pharmacy owners to meet the Pharmacy First monthly payment thresholds is a major ongoing concern, and the latest data highlights this burning issue.”

Janet noted that although the August adjustment provided some relief, Ministers must urgently take further action to support pharmacies through the planned increase in thresholds for September and October.

“Amidst a funding crisis, community pharmacies cannot afford to lose out on this vital payment,” she said.

Morrison stressed that community pharmacy has upheld its end of the agreement in launching the Pharmacy First service.

She called on NHS England to match this commitment with “more effective advertising and ensuring that GPs refer as many patients as possible.”

“We remain determined to push for full commitment on all sides to the shared objective of making the service a success, mindful that it is critical to the Government’s manifesto commitment to build on the service to create a wider Community Pharmacist Prescribing Service,” Janet added.

The CPE Committee recently conducted an opinion poll, inviting pharmacy owners to provide their insights and views on the rising Pharmacy First thresholds.

This feedback will be reviewed at the upcoming Community Pharmacy England Committee meeting in September.

Launched on January 31, 2024, the Pharmacy First service allows community pharmacies to offer advice to patients and supply NHS medicines (where clinically appropriate) to treat seven common health conditions without a prescription from a GP.

The seven conditions include earache, sore throat, sinusitis, impetigo, infected insect bites, shingles and urinary tract infections.

According to data from the NHS Business Services Authority (NHSBSA), from 31 January to 30 April 2024, over 9,976 community pharmacies delivered and claimed over 423,000 Pharmacy First clinical pathway consultations.

Of these consultations, 78 per cent resulted in a medicine being supplied to patients.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less